ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Infectious Agents and Disease
Probiotics and Amelioration of Periodontitis: Significant Roles of Lacticaseibacillus casei DS31
Provisionally accepted- 1Third Institute of Oceanography Ministry of Natural Resources, Xiamen, China
- 2Fujian Provincial Key Laboratory of Island Conservation and Development (Island Research Center, MNR), Xiamen, China
- 3Stomatologic Hospital of Xiamen Medical College, Xiamen, China
- 4School of Pharmacy and Pharmaceutical Sciences, Xiamen Medical College, Xiamen, China
- 5School of Stomatology, Xiamen Medical College, Xiamen, China
- 6Fujian Huijing Biological Technology CO., LTD, Zhangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Periodontitis, a chronic gum disease caused by Porphyromonas gingivalis infection, if left untreated, can result in tooth loss, alveolar bone loss, halitosis and other oral health complications. Methods: To investigate the preventive and therapeutic effects of Lacticaseibacillus casei DS31 from the large yellow croaker (Larimichthys crocea) on periodontitis, three experimental models— biofilm, cellular, and animal models—were established to systematically evaluate its efficacy. First, we sought to clarify the effect of DS31 against P. gingivalis biofilm. Then, the investigation entailed a comprehensive examination of the immunomodulatory effects of heat-inactivated probiotics on inflammation-inducing cells. Finally, the impact of probiotics on gingival tissue and alveolar bone was evaluated using an established periodontitis rat model. Results: The results demonstrated that bacteria suspension or cell-free supernatant of L. casei DS31 effectively inhibited P. gingivalis biofilm formation and eradicated existing biofilms, thereby reducing the secretion of pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) and inflammatory mediators (NO). Microcomputed tomography (micro-CT) and histopathological analysis revealed that supplementation with BS-DS31 or CFS-DS31 mitigated alveolar bone loss and increased bone mineral density in the experimental animals. The secretion of inflammatory factors (TNF-α, IL-1β, IL-6 and IL-8) in the gingival tissue of the rats was reduced. Conclusions: L. casei DS31 demonstrates significant potential for alleviating periodontitis and could serve as a promising probiotic candidate for incorporation into functional foods and oral health therapeutic applications.
Keywords: Lacticaseibacillus casei, Periodontitis, Porphyromonas gingivalis, Biofilm, Rats
Received: 29 Sep 2025; Accepted: 10 Nov 2025.
Copyright: © 2025 Liu, Wu, Li, Chen, Wang, Su, Luo, Cai, Huang and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xu Tang, tangxu@tio.org.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
